✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Biogen Inc

Common Name
Biogen
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
7,605
Ticker
BIIB
Exchange
NASDAQ/NGS
Description
Biogen Inc. is a globally recognized biotechnology company committed to discovering, developing, and delivering innovative therapies for neurological diseases. With a focus on serious medical conditio...

Biogen's Financial Statements Preview

Below are the financial statements of Biogen, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Current assets
Cash and cash equivalents
2,375a
1,049.9a
Accounts receivable, net
1,404.8a
1,664.1a
Due from anti-CD20 therapeutic programs
464a
435.9a
Inventory
2,460.5a
2,527.4a
Other current assets
752.5a
1,182a
Total current assets
7,456.8a
6,859.3a
Property, plant and equipment, net
3,181.3a
3,309.7a
Operating lease assets
356.4a
420a
Intangible assets, net
9,691.2a
8,363a
Goodwill
6,478.9a
6,219.2a
Deferred tax asset
324.2a
928.6a
Investments and other assets
560.5a
745a
Total assets
28,049.3a
26,844.8a
Liabilities and equity
Current liabilities
Current portion of notes payable and term loan
1,748.6a
150a
Taxes payable
548.3a
257.4a
Accounts payable
424.2a
403.3a
Accrued expense and other
2,807.7a
2,623.6a
Total current liabilities
5,528.8a
3,434.3a
Notes payable and term loan
4,547.2a
6,788.2a
Deferred tax liability
190.5a
641.8a
Long-term operating lease liabilities
334.5a
400a
Other long-term liabilities
732.3a
781.1a
Total liabilities
11,333.3a
12,045.4a
Equity: Biogen Inc. shareholders’ equity
Preferred stock
0a
0a
Common stock
0.1a
0.1a
Additional paid-in capital
569.4a
302.5a
Accumulated other comprehensive income (loss)
-136.2a
-153.7a
Retained earnings
19,259.8a
17,627.6a
Treasury stock, at cost
-2,977.1a
-2,977.1a
Total equity
16,716a
14,799.4a
Total liabilities and equity
28,049.3a
26,844.8a
Limited Data Preview
You are viewing a limited preview of Biogen’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Biogen’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biogen’s data sources below and access millions more through our Disclosure Search.

a. Biogen's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?